Fundraising FoxSharding Capital
Venture capitalPre-Seed–Seed · 9 people tracked
Find your way into Sharding Capital
Sign up to find every way you can get introduced to Sharding Capital
- Your email: who you already know at Sharding Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sharding Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Sharding Capital positions itself as an activist venture capital firm operating in the Web3 space. Beyond providing capital, it takes an active role in supporting its portfolio companies through mentorship, marketing strategies, and access to a broad network of founders, other venture capitalists, and key opinion leaders (KOLs). Its approach emphasizes hands-on involvement to help crypto and blockchain-focused startups grow.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & public directories
What they invest in
from 5 of 5 portfolio companiesBiotech ×3Healthtech ×3AI & Machine Learning ×2Medical Devices ×2Advanced Manufacturing ×1Crypto & Web3 ×1Data & Infrastructure ×1Deep Tech ×1
HQs:United States×5
Investments · 5 tracked
founders shown can be your intro path
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Jonathan Sporn, M.D.(President and Chief Executive Officer)in
Co-investorsAera VCAlumni VenturesFrontera Technology VenturesFrontier Path VCJames Beshara FundJLS+25 more
Heurist provides full-stack AI infrastructure for onchain applications, offering an aggregation layer for Web3 agents with over 100 verifiable crypto tools built on ERC-8004 and x402 payments.
AI & Machine LearningCrypto & Web3Data & InfrastructureNew York City, US
Co-investorsRR2 CapitalAmber GroupDCF GodManifold VenturesMozaik CapitalOrigin Capital+2 more
TransAstra develops propulsion systems and telescope technology for space operations.
Advanced ManufacturingSpace TechLos Angeles, US
Joel Sercel(Founder)in
Co-investorsJude GomilaSoma CapitalValkyrieY CombinatorAcequia Capital (AceCap)Cathexis Ventures+9 more
Volumetric Biotechnologies, acquired by 3D Systems in 2021, develops bioprinting materials and vascularized human tissue constructs.
BiotechDeep TechHealthtechMedical DevicesHouston, US
Jordan Miller(Co-Founder and President)inBagrat Grigoryan(Co-Founder, COO)in
Co-investorsGoAhead VenturesHarmonix FundHelios CapitalJoyance PartnersJude GomilaSand Hill Angels+20 more
YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.
BiotechHealthtechMedical DevicesSan Francisco, US
Akash Bakshi(Founder)inNadja Mannowetz(Founder)in
Co-investorsBlue Bear VenturesForeground CapitalOlive Tree CapitalPortfoliaY Combinator8VC+9 more
Exits · 1
1 acquisitionsVolumetricacq. by 3D Systems
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Sharding Capital made?
- Sharding Capital has 5 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Sharding Capital invest at?
- Sharding Capital invests at the Pre-Seed, Seed stages.
- What sectors does Sharding Capital focus on?
- Sharding Capital focuses on Crypto & Web3.
Similar investors
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Cherubic Ventures is known for investing before a startup even launches or reaches product-market fit, often as the first institutional investor, while also setting aside half of its latest fund for follow-on support all the way through pre-IPO; it was also one of the first venture firms to operate as a solo general partner and has grown into one of the largest funds run that way. Founded by Matt Cheng, who previously built two companies that each reached over $1 billion in public market value, the firm was designed from the start to invest across both the U.S. and Asia, backing early breakout companies in places like Croatia, Bangladesh, Japan, and Taiwan in addition to the U.S., with its Taipei roots still central to its identity alongside its Silicon Valley presence.
Hoxton Ventures is an early-stage venture capital firm that backs pre-seed and seed companies, often investing before revenue or product and offering hands-on support to founders.